Quisinostat
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Quisinostat, covering 2016-05-03 to 2026-03-17. Get the full timeline:
Most recent: Clinical Trial Update: Phase 0 With Expansion Phase Clinical Trial of Quisinostat Plus Radiotherapy in Newly-diagnosed and Recurrent Grade 4 IDH-Wildtype Glioblastomas [EARLY_Phase 1]